Reviva Pharmaceuticals Holdings, Inc. (RVPH)
0.3676
+0.03
(+8.12%)
USD |
OTCM |
Nov 06, 16:00
Reviva Pharmaceuticals Holdings Price to Book Value : 0.3169 for Nov. 6, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 06, 2026 | 0.3169 |
| November 05, 2026 | 0.2931 |
| November 04, 2026 | 0.3276 |
| November 03, 2026 | 0.3457 |
| November 02, 2026 | 0.3698 |
| October 30, 2026 | 0.3017 |
| October 29, 2026 | 0.3375 |
| October 28, 2026 | 0.3578 |
| October 27, 2026 | 0.388 |
| October 26, 2026 | 0.3669 |
| October 23, 2026 | 0.3862 |
| October 22, 2026 | 0.4095 |
| October 21, 2026 | 0.3828 |
| October 20, 2026 | 0.3966 |
| October 19, 2026 | 0.388 |
| October 16, 2026 | 0.4056 |
| October 15, 2026 | 0.4095 |
| October 14, 2026 | 0.4123 |
| October 13, 2026 | 0.427 |
| October 12, 2026 | 0.4224 |
| October 09, 2026 | 0.4311 |
| October 08, 2026 | 0.4267 |
| October 07, 2026 | 0.4311 |
| October 06, 2026 | 0.4405 |
| October 05, 2026 | 0.4397 |
| Date | Value |
|---|---|
| October 02, 2026 | 0.4311 |
| October 01, 2026 | 0.4311 |
| September 30, 2026 | 0.4052 |
| September 29, 2026 | 0.4112 |
| September 28, 2026 | 0.4122 |
| September 25, 2026 | 0.4138 |
| September 24, 2026 | 0.4483 |
| September 23, 2026 | 0.4138 |
| September 22, 2026 | 0.4552 |
| September 21, 2026 | 0.4311 |
| September 18, 2026 | 0.4138 |
| September 17, 2026 | 0.4328 |
| September 16, 2026 | 0.4224 |
| September 15, 2026 | 0.4138 |
| September 14, 2026 | 0.4138 |
| September 11, 2026 | 0.4611 |
| September 10, 2026 | 0.4311 |
| September 09, 2026 | 0.459 |
| September 08, 2026 | 0.4642 |
| September 04, 2026 | 0.4569 |
| September 03, 2026 | 0.4655 |
| September 02, 2026 | 0.4612 |
| September 01, 2026 | 0.4397 |
| August 31, 2026 | 0.4138 |
| August 28, 2026 | 0.447 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ANI Pharmaceuticals, Inc. | 2.423 |
| Corcept Therapeutics, Inc. | 9.546 |
| Veru, Inc. | 1.274 |
| Johnson & Johnson | 8.155 |
| Eli Lilly & Co. | 31.65 |
Price to Book Value Related Metrics
| Price | 0.3676 |
| Earnings Yield | -630.4% |
| Market Cap | 4.819M |